FDA approves weight-loss drug Zepbound for obstructive sleep apnea

https://www.cnn.com/2024/12/20/health/zepbound-sleep-apnea-fda-approval/index.html

CNN comments "Although the new FDA green light doesn’t expand the number of people who may be eligible for the drug, since the sleep apnea approval is specifically for people with obesity, it could lead to insurance coverage for those with the condition on Medicare, which doesn’t cover drugs solely for weight loss."